Brain imaging screening in #MetastaticBreastCancer: Is it time to rethink clinical guidelines and practice? In this recent editorial Drs. Sarah Sammons, Nayan Lamba and Nancy Lin present some compelling reasons: 🔦Screening for #BrainMetastasis (BM) is associated with clinically relevant rates of detection of asymptomatic disease 🔦Screening for #BrainMets leads to diagnosis of smaller and fewer lesions, prior to the development of neurologic symptoms 🔦Advanced radiation oncology techniques are safer and more effective for smaller #CNS system lesions 🔦Treating patients with asymptomatic/occult lesions may result in better outcomes 🔦Advances in systemic treatments have expanded treatment options and improved outcomes for patients with BM, particularly in HER2+ #MBC 🔦The identification of asymptomatic BM on brain imaging scans can lead to changes in treatment strategy. Read the full editorial ⬇️ 🔓thebreastonline.com/article/… #BCBM @drsarahsam @NayanLamba @nlinmd #BreastCancer